What moron bought this dog for 2.9 billion dollars? Now you know how the rest of us feel having been overpromised and underdelivered. I saw where your CEO said that he sees this being a 1 billion dollar a year drug. And I heard that the lung data was not nearly as promising as once thought. We have heard the same old song and dance for years but Patrick always seems to come out on top.
You will wish you never bought this drug. Especially when patent expires in 2013. Don't believe the leadership with this absurd 2025 patent protection.
HAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHA and NO reps in the field to sell this drug...have to hire and train practically a whole new sales force...wow... If you have stock sell it now...what a disaster buy
Do you REALLY believe the BUY was for ABRAXANE or the people? More likely "NAB"ed for its SOLID technology...
If that is true why does the ceo keep saying they expect 1b sales with just breast and over with other indications. They also have nothing to wall street about using this technology elsewhere. If they actually had plans to do that they would be screaming it from the mountaintops to get the play on wall street. Think about it. Put down the cool aide.
lol....looks like Celgene struck out on the drug and the people. WOW. I can't believe our management got Patricked....but they surely did.
